Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.74 USD | -5.50% | -7.79% | -19.46% |
May. 01 | Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year | MT |
May. 01 | Bausch + Lomb Q1 Loss Widens, Revenue Increases | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.46% | 4.83B | |
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.52B | |
+1.43% | 50.06B | |
+11.60% | 45.67B | |
+3.40% | 41B | |
+3.03% | 26.73B | |
+3.21% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Bausch + Lomb and Modulight Announcing FDA Approval of ML6710i Photodynamic Laser for Use with BLCO's VISUDYNE (Verteporfin for Injection)